Multi-analyte procedures for screening for and quantification of drugs in blood, plasma, or serum by liquid chromatography-single stage or tandem mass spectrometry (LC-MS or LC-MS/MS) relevant to clinical and forensic toxicology.
about
Principles and applications of liquid chromatography-mass spectrometry in clinical biochemistryRole of liquid chromatography-high-resolution mass spectrometry (LC-HR/MS) in clinical toxicology.Screening for amphetamine and amphetamine-type drugs in doping analysis by liquid chromatography/mass spectrometry.Rapid genotyping of single nucleotide polymorphisms influencing warfarin drug response by surface-enhanced laser desorption and ionization time-of-flight (SELDI-TOF) mass spectrometry.Development and practical application of a library of CID accurate mass spectra of more than 2,500 toxic compounds for systematic toxicological analysis by LC-QTOF-MS with data-dependent acquisition.Fragmentation of toxicologically relevant drugs in positive-ion liquid chromatography-tandem mass spectrometry.Analyses of benzodiazepines and their metabolites in various biological matrices by LC-MS(/MS).Recent application of analytical methods to phase I and phase II drugs development: a review.Method validation and determination of lisdexamfetamine and amphetamine in oral fluid, plasma and urine by LC-MS/MS.Absolute Quantification of Rifampicin by MALDI Imaging Mass Spectrometry Using Multiple TOF/TOF Events in a Single Laser Shot.Mass spectrometry-based proteomics as a tool to identify biological matrices in forensic scienceBio-sample preparation and analytical methods for the determination of tricyclic antidepressants.Aspects of matrix effects in applications of liquid chromatography-mass spectrometry to forensic and clinical toxicology--a review.Multi-target screening of biological samples using LC-MS/MS: focus on chromatographic innovations.Chemiluminescence microarrays in analytical chemistry: a critical review.Liquid chromatography tandem mass spectrometry in the clinical laboratory.Assessment of simpler calibration models in the development and validation of a fast postmortem multi-analyte LC-QTOF quantitation method in whole blood with simultaneous screening capabilities using SWATH acquisition.Dating bloodstains with fluorescence lifetime measurementsSimultaneous Screening of 177 Drugs of Abuse in Urine Using Ultra-performance Liquid Chromatography with Tandem Mass Spectrometry in Drug-intoxicated Patients.Difficult-to-control arterial hypertension or uncooperative patients? The assessment of serum antihypertensive drug levels to differentiate non-responsiveness from non-adherence to recommended therapy.Oxidation of Selected Phenothiazine Drugs During Sample Preparation: Effects of Varying Extraction Conditions on the Extent of Oxidation.Detection and quantification of benzodiazepines and Z-drugs in human whole blood, plasma, and serum samples as part of a comprehensive multi-analyte LC-MS/MS approach.Fast screening of 88 pharmaceutical drugs and metabolites in whole blood by ultrahigh-performance liquid chromatography-tandem mass spectrometry.Profiles in drug metabolism and toxicology: Richard Tecwyn Williams (1909-1979).Development and validation of a dynamic range-extended LC-MS/MS multi-analyte method for 11 different postmortem matrices for redistribution studies applying solvent calibration and additional (13)C isotope monitoring.Chromatographic behavior of co-eluted plasma compounds and effect on screening of drugs by APCI-LC-MS(/MS): Applications to selected cardiovascular drugs.Determination of illicit drugs and metabolites in oral fluid by microextraction on packed sorbent coupled with LC-MS/MS.Use of Xylazine in Drug-Facilitated Crimes.Clinical Mass Spectrometry in the Bioinformatics Era: A Hitchhiker's Guide
P2860
Q24653004-14A9FA2E-20D3-4D1B-9174-A334D9AF0CE4Q31083824-9CC960C3-7FFD-434A-9FB9-36290CD8AEB6Q33434788-FE05D604-17C8-4F6C-8E94-C0CF4536ED8DQ33523960-99299256-B973-4CCC-98FC-3AFCAA008EA7Q33762355-20648E6F-15A1-48F6-95A2-EF5E52EAB8A3Q33811853-E2DFFA84-D741-42E5-A40C-D492E0A3CCF1Q33844976-05CA7C68-4A3C-4FE8-883F-E30C0BADC010Q33997398-1FA21AC4-74AE-4879-B1DC-730250CA8110Q36102896-47102194-B0A4-4714-81A9-D8ACC1A55170Q36140124-05FECE3A-D2C7-4DC1-AF02-C98D80D56AA2Q36627880-1B46335A-1A6D-403D-A95F-31122B49880FQ37822787-37B03024-56FE-48E3-825D-3DD2004A944AQ38006891-CBD30BDD-8252-413E-8C76-846070A54A15Q38221657-A0F61B48-4ABA-411D-AFAC-E4C636D9DA72Q38227132-FF269FB6-D6D4-41E8-8781-B30216CE5619Q38260022-E942655B-25E4-453C-B7C1-F7E952905ED4Q38602710-FF3C229A-7A77-4F66-BB5B-34B7DB3FF1F9Q41290720-56D2CE9F-8909-4B3F-B5AE-AE431A8B7F12Q41883054-9F253C68-E8A7-42C8-A77A-1793494ABEA3Q44800320-A6F6CBF2-6B93-4637-B9E9-19ACCF6F2A7DQ44877441-5D89425B-A75A-44F9-BC08-EE5FE726AD12Q44881743-EF1410AE-2D6B-46D7-83C7-170848103217Q45396704-C8D2EB9B-0FED-42AD-A078-E893C99AFF88Q46633307-07DFA6E3-EC03-4AB0-B34C-00812FB5D0DEQ48943857-8CFD5DF6-5BC8-4597-B997-DADDAE145889Q50177913-23287E34-EFC7-49A6-9D3E-71B4A59489FCQ50593926-054F91EE-BE58-4719-87A3-20F3E0E4F697Q52817114-FCDF4783-62FF-4BF1-8D50-5C2F206A2DD1Q58697507-D849D302-77B8-41CB-AF81-2B88AE886738
P2860
Multi-analyte procedures for screening for and quantification of drugs in blood, plasma, or serum by liquid chromatography-single stage or tandem mass spectrometry (LC-MS or LC-MS/MS) relevant to clinical and forensic toxicology.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Multi-analyte procedures for s ...... nical and forensic toxicology.
@ast
Multi-analyte procedures for s ...... nical and forensic toxicology.
@en
type
label
Multi-analyte procedures for s ...... nical and forensic toxicology.
@ast
Multi-analyte procedures for s ...... nical and forensic toxicology.
@en
prefLabel
Multi-analyte procedures for s ...... nical and forensic toxicology.
@ast
Multi-analyte procedures for s ...... nical and forensic toxicology.
@en
P1476
Multi-analyte procedures for s ...... nical and forensic toxicology.
@en
P2093
Hans H Maurer
P304
P356
10.1016/J.CLINBIOCHEM.2005.01.014
P577
2005-04-01T00:00:00Z